Marcos Pedro Guedes Camandaroba

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Vinícius F. Calsavara et al. · Therapeutic Advances in Medical Oncology · 2020 · 37 citations · Full text

Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma

Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio et al. · Journal of Gastrointestinal Oncology · 2018 · 35 citations · Full text

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients

Jianzhou Chen, Antonin Lévy, Ai-Ling Tian et al. · Cancer Cell · 2025 · 32 citations · Full text

Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis

Marcos Pedro Guedes Camandaroba, Raphael L. C. Araújo, Virgílio Souza e Silva et al. · Journal of Gastrointestinal Oncology · 2018 · 24 citations · Full text